Enveric Biosciences has confirmed it has completed the manufacture of its lead drug candidate – EB-373 – a New Chemical Entity (NCE) designed as a next-generation...
Cybin Inc.
UK-based COMPASS Pathways has secured $285 million in funding through a private placement to support its research in psychedelic medicines.
The first-ever Professional Practice Guidelines for psychedelic therapy in the US have been published by the American Psychedelic Practitioners Association (APPA) and BrainFutures.
PharmAla Biotech Holdings has announced that it has issued a shipment of its GMP LaNeo MDMA to Mind Medicine Australia.
MGC Pharmaceuticals has received permission to import psilocybin into Slovenia.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
A group of experts has published a paper in the American Journal of Psychiatry examining the definition of “psychedelic-assisted psychotherapy” using psilocybin.
In what marks a positive development for patient access to psychedelic therapies in the US, the American Medical Association has released the language of its first-ever...
Psychedelic Medicine Investment Fund Negev Capital is aiming to innovate mental healthcare in Europe by providing funding to companies on the cutting edge of psychedelic research.
